Kaplan-Meier analyses demonstrated that the high level of TRAF6 expression predicted a short-term DFS (P < 0.0001) and OS (P < 0.0001; Figure 3E and 3F and Supplementary Figure S1C and S1D) in glioma patients. This evidence concerns the gene TRAF6 and central nervous system cancer.